Skip to main content
Log in

EEG Characteristics of Successful Burst Suppression for Refractory Status Epilepticus

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Refractory status epilepticus (RSE) is often treated with continuous intravenous medications with the goal of EEG burst suppression. Standard advice is to titrate medications to at least 10-s interburst intervals; however, this has not been shown to improve outcome. We examined EEG characteristics in patients treated with IV anesthetic therapy (IVAT) for RSE to determine which EEG characteristics were associated with successful lifting of IVAT (i.e., without recurrence of status epilepticus).

Methods

We screened the clinical continuous EEG database for adult patients treated with IVAT for RSE (excluding patients with anoxic injury). We measured the length of bursts and interburst intervals for each patient, calculated EEG burst suppression ratios, and graded bursts for the amount of epileptiform activity. We compared these characteristics in successful versus unsuccessful IVAT lifting attempts.

Results

We included 17 successful and 20 unsuccessful lifting attempts in 19 patients (5 used as a holdout validation set). The interburst intervals, burst suppression ratios, and length of bursts did not differentiate successful and unsuccessful lifting attempts; the amount of epileptiform activity in bursts correlated with success or failure to wean IVAT (p = 0.008). Maximum burst amplitude <125 μV had 84.6 % sensitivity and 61.1 % specificity for predicting successful lifting.

Conclusion

The length of interburst intervals and burst suppression did not predict successful termination of RSE in this small cohort. This may suggest that EEG characteristics, rather a strict interburst interval goal, could guide IVAT for RSE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hirsch LJ, Gaspard N. Status epilepticus. Continuum. 2013;19:794–7.

    Google Scholar 

  2. Allredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. NEJM. 2001;345:631–7.

    Article  Google Scholar 

  3. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.

    Article  PubMed  Google Scholar 

  4. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–702.

    Article  PubMed  Google Scholar 

  5. Rossetti AO, Reichhart MD, Schaller M, Despland P, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45:757–63.

    Article  CAS  PubMed  Google Scholar 

  6. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922–30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sahin M, Menache CC, Holmes GL, Riviello JJ Jr. Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children. Neurology. 2003;61:398–401.

    Article  PubMed  Google Scholar 

  8. Krishnamurthy KB, Drislane FB. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759–62.

    Article  CAS  PubMed  Google Scholar 

  9. Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72–7.

    Article  PubMed  Google Scholar 

  10. Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40:2677–84.

    Article  CAS  PubMed  Google Scholar 

  11. Sutter R, Kaplan PW, Marsch S, Hammel EM, Ruegg S, Ziai WC. Early predictors of refractory status epilepticus: an international two-center study. Eur J Neurol. 2015;22:79–85.

    Article  CAS  PubMed  Google Scholar 

  12. Fernandez A, Lantigua H, Lesch C, et al. High-dose midazolam infusion for refractory status epilepticus. Neurology. 2014;82:359–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status epilepticus severity score: a tool to orient early treatment strategy. J Neurol. 2008;255:1561–6.

    Article  PubMed  Google Scholar 

  14. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23.

    Article  PubMed  Google Scholar 

  15. Bergey GK. Refractory status epilepticus: is EEG burst suppression an appropriate treatment target during drug-induced coma? what is the holy grail? Epilepsy Curr. 2006;6:119–20.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hofmeijer J, Beernink T, Bosch F, et al. Early EEG contributes to multimodal outcome prediction of postanoxic coma. Neurology. 2015;85:137–43.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Akrawi WP, Drummond JC, Kalkman CJ, Patel PM. A comparison of the electrophysiologic characteristics of EEG burst-suppression as produced by isoflurane, thiopental, etomidate, and Propofol. J Neurosurg Anesthesiol. 1996;8:40–6.

    Article  CAS  PubMed  Google Scholar 

  18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.

    Article  CAS  PubMed  Google Scholar 

  19. Mani R, Arif H, Hirsch LJ, Gerard EE, LaRoche SM. Interrater reliability of ICU EEG research terminology. J Clin Neurophysiol. 2012;29:203–12.

    Article  PubMed  Google Scholar 

  20. Thompson SA, Hantus S. Highly epileptiform bursts are associated with seizure recurrence. J Clin Neurophysiol. 2016;33:66–71.

    Article  PubMed  Google Scholar 

  21. Sutter R, Marsch S, Fuhr P, Kaplan P, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;25:656–64.

    Article  Google Scholar 

  22. Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85:495–500.

    Article  Google Scholar 

  23. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.

    Article  CAS  PubMed  Google Scholar 

  24. Kang BS, Jung KH, Wu C, et al. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus. J Clin Neurosci. 2015;22:854–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emily L. Johnson.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Research Involved in Human Participants

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johnson, E.L., Martinez, N.C. & Ritzl, E.K. EEG Characteristics of Successful Burst Suppression for Refractory Status Epilepticus. Neurocrit Care 25, 407–414 (2016). https://doi.org/10.1007/s12028-016-0294-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-016-0294-2

Keywords

Navigation